Moreover, in close collaboration with Sanofi Internal Audit and Internal Control & Processes teams, it
ensures that risk assessment and reporting activities are effective and proposes relevant adaptations to
the Risk Committee.
Besides the above-described recurrent activities, the Sanofi Risk Management team participates on a need
basis to specific assignments such as:
contributing to prepare scenarios figuring out threats and opportunities for the Company, in relation
with climate transition. For more information, see our Document Center: Climate-related Financial
Disclosures on Risks and Opportunities related to Climate Change (TCFD) Factsheet.
leading a task force gathering representatives of various Global Functions in order to assess long- term
perspectives on the evolution of healthcare systems in key markets.
2.3. RISK MANAGEMENT NETWORK
Operational risk managers are appointed by the senior management of Global Business Units and Global
Functions and are members of the Risk Management network. They are in charge of establishing risk
profiles and monitoring mitigation plans within their area of responsibility. Their role is also to contribute
to updating and enriching the Sanofi risk profile and the continuous improvement of policy, guidance and
tools governing risk management.
The Risk Management network is a catalyst for developing a framework and disseminating a risk
management culture across the Company through dedicated workshops and specific events designed to
thoroughly analyze and address specific risk areas, with the active involvement and coordinated efforts of
many different stakeholders.
In order to ensure Sanofi Risk Management methodology consistency across Global Business Units and
Global Functions, each new network member receives a comprehensive training to the tasks they are
expected to complete. This training is provided by Sanofi Risk Management team based on dedicated
modules.
3. Risk management approach
Our risk management approach relies on a comprehensive risk assessment process that includes risks and
emerging risks identification and evaluation, risks treatment and for a selection of emerging risks, set up
of scenarios to figure out how they would impact the company. This methodology allows us to capture all
categories of opportunities and threats closely tied to our strategy and inherent to our business. Time
horizon considered is up to 3 years for active risks and up to 7 years and beyond for emerging risks.
In 2021, an external evaluation of Sanofi Risk Management practices was carried out by Deloitte with the
following conclusion: SRM process “is characterized by both its solidity and flexibility. It is aligned with
market best practices and is adapted to Sanofi Group culture. The alignment between risk methodology
and business strategy has reinforced its acceptance and embedment in the Group, leading to an increasing
risk culture and awareness”. Some recommendations for further improvement were issued regarding risk
governance, infrastructure, and process.
A dedicated risk management information system is in place and enables authorized users to manage all
steps of the risk and emerging risks management process.
3.1. RISKS & EMERGING RISKS IDENTIFICATION
Sanofi Risk Management team performs a prospective survey based on reports and insights issued by the
World Economic Forum, audit and consulting firms, banks and insurance companies, and investigations on
the internet from selected reliable sources, regarding trends for the coming years and main threats and
opportunities to be anticipated by pharma and biotech industry, in order to raise awareness over actual
and emerging risks context. This prospective survey is updated twice each year in Q1 (to identify short